Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Finding new and better treatments for psychiatric disorders
    Published on 2023-08-15
    3 years ago
  • Calcitonin receptor signal: a potential target for opioid use disorder?
    Published on 2023-08-14
    3 years ago
  • Unraveling the cell-type-specific molecular pathways of PTSD: integrating GWAS with brain genomic profiling and in vitro modeling
    Published on 2023-08-14
    3 years ago
  • Towards personalized medicine: subtyping using functional profiles
    Published on 2023-08-14
    3 years ago
  • Postmortem-derived iPSC models in substance use disorders research
    Published on 2023-08-14
    3 years ago
  • A path to novel, effective treatments for schizophrenia
    Published on 2023-08-14
    3 years ago
  • Transcranial focused ultrasound (tFUS): a promising noninvasive deep brain stimulation approach for pain
    Published on 2023-08-10
    3 years ago
« Previous 1 … 105 106 107 108 109 … 143 Next »
Journal of Psychopharmacology
  • Acute subjective effects in LSD- and MDMA-assisted psychotherapy
    Published on 2020-10-09
    6 years ago
  • Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
    Published on 2020-10-09
    6 years ago
  • Selective activation of D1 dopamine receptors exerts antidepressant-like activity in rats
    Published on 2020-10-09
    6 years ago
  • Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
    Published on 2020-09-10
    6 years ago
  • Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale
    Published on 2020-09-09
    6 years ago
  • Antidepressant responses in direct comparisons of melancholic and non-melancholic depression
    Published on 2020-09-09
    6 years ago
  • Neurobiological mechanisms associated with antipsychotic drug-induced dystonia
    Published on 2020-09-09
    6 years ago
« Previous 1 … 105 106 107 108 109 … 145 Next »
European Neuropsychopharmacology
  • Are we ready for precision medicine for Autism? And who wants it?
    Published on 2021-04-12
    5 years ago
  • Drug development in ASD, an ISCTM-ECNP joint adventure
    Published on 2021-04-06
    5 years ago
  • GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site
    Published on 2021-04-03
    5 years ago
  • Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis
    Published on 2021-04-03
    5 years ago
  • Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEPS)
    Published on 2021-04-03
    5 years ago
  • Comorbidities and behavioral issues
    Published on 2021-04-02
    5 years ago
  • Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk
    Published on 2021-04-02
    5 years ago
« Previous 1 … 105 106 107 108 109 … 166 Next »

   Pharma Pub